Results 91 to 100 of about 11,837 (160)

Effectiveness of Ceftazidime/Avibactam treatment for infections caused by Klebsiella pneumoniae Carbapenemase (KPC), a 30-day mortality perspective. Comparison of results with control groups treated with other antibiotics

Journal of Education, Health and Sport
Introduction: Infections caused by Klebsiella pneumoniae carbapenemase (KPC) pose a significant clinical challenge due to increasing antibiotic resistance.
Patrycja Paschke, Igor Miczek, Maria Sambura, Sara Rosołowska-Żak, Julia Pałuchowska, Anna Szymkowicz   +5 more
doaj   +1 more source

Ceftazidime–Avibactam Pharmacokinetic Comparative In Vivo/In Vitro Study in a Critically Ill Children Under High‐Volume Continuous Venovenous Hemodiafiltration

Pharmacology Research & Perspectives
Ceftazidime–avibactam is a novel cephalosporin/beta‐lactamase inhibitor combination developed to address increasing antimicrobial resistance. This report presents a comparative study of the pharmacokinetics of ceftazidime and avibactam, utilizing in ...
Michael Thy, Alexandre Debs, Gabrielle Lui, Leo Froelicher‐Bournaud, Jean‐Marc Tréluyer, Mehdi Oualha   +5 more
doaj   +1 more source

Fitness cost of ceftazidime-avibactam resistance acquisition in carbapenem-resistant hypervirulent Klebsiella pneumoniae. [PDF]

BMC Microbiol
Huang M, Xiao SP, Zeng QH, Guo HM, Liu YT, Wei DD, Kang XH.   +6 more
europepmc   +1 more source

Ceftazidime/Avibactam Monotherapy Versus Other Antibiotics: Where Do We Stand? [PDF]

Pathogens
Vougiouklakis G, Tsioutis C, Vasileiadi N, Alexakis K, Spernovasilis N, Agouridis AP.   +5 more
europepmc   +1 more source

Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China. [PDF]

Front Cell Infect Microbiol
Qin X, Xiang T, Zhang X, Ma X, Zhao W, Yu Y, Zhao C, Gao L, Li L, Wang T, Pang C, Zhao X, Han R, Cao F, Su M, Lu J, Xu W, Yin S, Lu D, Yang X, Wang M.   +20 more
europepmc   +1 more source

Prevalence, Antimicrobial Susceptibility, and Molecular Characteristics of Ceftazidime-Avibactam-Resistant <i>Klebsiella pneumoniae</i> in a Chinese Hospital. [PDF]

Infect Drug Resist
Li J, Wang H, Liu Z, Xia Y, Hu Y, Wang H, Xia F, Zou M.   +7 more
europepmc   +1 more source

Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>. [PDF]

Antimicrob Agents Chemother
Karunanidhi A, Singh N, Watkins JV, Smith NM, Zang Y, Shan X, Espinoza G, Li J, Lang Y, Bulitta JB, Bulman ZP.   +10 more
europepmc   +1 more source

Ceftazidime-Avibactam in Critically Ill Patients: A Multicenter Observational Study. [PDF]

Antibiotics (Basel)
Silvia O, Mazzanti S, Gelo Signorino G, Pallotta F, Ficola A, Canovari B, Di Muzio V, Di Prinzio M, Cerutti E, Donati A, Giacometti A, Barchiesi F, Brescini L.   +12 more
europepmc   +1 more source

Ceftazidime-Avibactam: A Retrospective Analysis of Multicenter Real-World Data and Factors Affecting Mortality. [PDF]

Infect Dis Clin Microbiol
Aktuğ Demir N, Temoçin F, Ural O, Gülten E, İnal AS, İnal AS, Kader Ç, Ersoy Y, Asan A, Aysert Yıldız P, Sümer Ş, Arslan E, Gezer Y, Çınar G, Sarıcaoğlu EM, Tatlı Kış TT, Özçimen S, Öztürk B, Sarıkaya B, Türkmen M, Kuruoğlu T, Atasoy Tahtasakal C, Yılmaz E.   +22 more
europepmc   +1 more source

Antimicrobial Susceptibility of Ceftazidime-Avibactam in Clinical Isolates of Carbapenemase-Producing Enterobacterales. [PDF]

Cureus
Jain S, Vyas A, Chaturvedi P.
europepmc   +1 more source